Topical pharmacotherapies offer the unique advantage that the products are applied directly to the diseased skin, resulting in local, distinctly direct contact between the product and the affected skin. The choice of vehicle depends on the type of dermatosis. Vehicle polarity and vehicle viscosity result in optimal contact between the vehicle and affected skin, allowing uncomplicated application and distribution of the product.
Autoren
- Prof. Dr. phil. nat. Christian Surber
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Study report
Sphingolipid profile in early-stage primary biliary cholangitis
- Angiosarcoma of the heart
A diagnostic and therapeutic “black box”
- Ataxias
Friedreich’s ataxia: when the energy metabolism attacks the nervous system
- Risk of osteoporosis in autoimmune liver diseases
Always determine bone density in PBC, PSC and AIH
- Case report: Complication after type 2 diabetes
Topical corticosteroids lead to ketoacidosis
- NSCLC
Bispecific antibodies for rare EGFR mutations
- Type 2 diabetes - glycemic control and prevention of secondary diseases
Utilizing pleiotropic cardio- and nephroprotective effects of SGLT-2-i and GLP-1-RA
- Subsyndromal anxiety disorders: Family doctor as first point of contact